// App-Quantinova.ai

2540 : Disruption of a TGF-CTCF regulated pathway leads to cancer stem cells

Researchers

Presenter

  • Jian Chen

Principal Investigators

  • Zhixing Yao

  • Jiun-Sheng Chen

  • Young Jin Gi

  • Yun Seong Jeong

  • Wilma Jogunoori

  • Mitchell Belkin

  • Bibhuti Mishra

  • Jon White

  • Abhisek Mitra

  • Shulin Li

  • Milton Finegold

  • Marta Davila

  • Jerry Shay

  • Keigo Machida

  • Hidekazu Tsukamoto

  • Lopa Mishra

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Georgetown University, Washington, DC

  • 1.MD Anderson Cancer Center, Houston, TX

  • Institute of Clinical Research, VA Medical Center, Washington, DC

  • Baylor College of Medicine, Houston, TX

  • UTSouthwestern Medical Center, Dallas, TX

  • University of Southern California, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Beckwith–Wiedemann syndrome

  • Solid malignancies

Biomarkers

  • Cyclin dependent kinase inhibitor 1C

  • Insulin Like Growth Factor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved